Provided by Tiger Trade Technology Pte. Ltd.

Accendra Health Inc

0.2031
-0.0950-31.87%
Post-market: 0.21500.0119+5.86%19:55 EST
Volume:2.90M
Turnover:616.07K
Market Cap:15.62M
PE:-0.05
High:0.2450
Open:0.2442
Low:0.2005
Close:0.2981
52wk High:4.69
52wk Low:0.1910
Shares:76.90M
Float Shares:56.17M
Volume Ratio:0.33
T/O Rate:5.17%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.9457
EPS(LYR):-14.3179
ROE:-198.35%
ROA:0.69%
PB:-0.03
PE(LYR):-0.01

Loading ...

Accendra Health is Maintained at Neutral by UBS

Dow Jones
·
Aug 14

UBS Adjusts Price Target on Accendra Health to $1.50 From $4.50, Keeps Neutral Rating

MT Newswires Live
·
Aug 13

U.S. Research Roundup-Airbnb, Five Below, Silgan Holdings

Reuters
·
Aug 13

Press Release: Chemtrade Logistics Income Fund Announces Results for the Second Quarter of 2026 and Reiterates 2026 Adjusted Ebitda Guidance of $485 to $525 Million

Dow Jones
·
Aug 13

Accendra Health Cut to Neutral from Buy by Citigroup

Dow Jones
·
Aug 11

Citigroup Downgrades Accendra Health to Neutral From Buy, Adjusts PT to $1.50 From $4.50

MT Newswires Live
·
Aug 11

Baird Downgrades Accendra Health to Neutral From Outperform, Adjusts PT to $1.50 From $6

MT Newswires Live
·
Aug 11

U.S. Research Roundup-Accendra Health, Celestica, Sionna Therapeutics

Reuters
·
Aug 11

Accendra Health Inc : Baird Cuts to Neutral Rating; Cuts Target Price to $1.5 from $6

THOMSON REUTERS
·
Aug 11

US Closing Bell | Megacaps resist mild pullback as Dow edges 0.1% lower

US Closing Bell
·
Aug 11

Accendra Health Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 10

Accendra Health Shares Slip on Sales-View Cut, Impending CEO Exit

Dow Jones
·
Aug 10

Accendra Health Says Q2 2026 Results Miss Forecast on Weaker Revenue Growth, Slower Collections Recovery

Reuters
·
Aug 10

Accendra Health adopts Section 382 Rights Agreement

TIPRANKS
·
Aug 10

Accendra Health Q2 Profit, Revenue Miss Estimates on Large Payor Exit

Reuters
·
Aug 10

Accendra Health Updates Financial Calendar with Investor Call for Quarterly Results

Reuters
·
Aug 10

Accendra Health Q2 2026 Adjusted Ebitda Drops to $60 Million; GAAP Continuing-Ops Net Loss Widens to $89 Million

Reuters
·
Aug 10

Accendra Health, Inc Q2 Adjusted Ebitda USD 60.1 Million Vs. IBES Estimate USD 61.3 Million

Reuters
·
Aug 10

Accendra Health Chief Executive Edward Pesicka to Retire

MT Newswires Live
·
Aug 10

Accendra Health, Inc Q2 Revenue USD 613.2 Million VS. Ibes Estimate USD 627.3 Million

THOMSON REUTERS
·
Aug 10